BRINZOLAMIDE VIATRIS 10 mg/ml, eye drop suspension bottle, 5 ml
Active ingredients: Brinzolamide
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop suspensionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRINZOLAMIDE VIATRIS 10 mg/ml, collyre en suspension
- Pharmaceutical form
- collyre en suspension
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène basse densité (PEBD) de 5 ml avec compte-gouttes (PEBD)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Mar 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67780625CIP73003288CIP133400930032886Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BRINZOLAMIDEcollyre | 10 mg · 1 ml de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.